Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prion diseases].

J J Zarranz

    Neurologia (Barcelona, Spain)
    |October 3, 2006
    PubMed
    Summary
    This summary is machine-generated.

    Prion diseases, including variant Creutzfeldt-Jakob disease (vCJD), are underdiagnosed, posing public health challenges. Surveillance systems may struggle to detect future atypical vCJD cases, questioning current classification methods.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Iowa APP mutation-related hereditary cerebral amyloid angiopathy (CAA): A new family from Spain.

    Journal of the neurological sciences·2016
    Same author

    Cardiocirculatory manifestations in Parkinson's disease patients without orthostatic hypotension.

    Journal of human hypertension·2015
    Same author

    Motor and non-motor symptoms of Parkinson's disease and their impact on quality of life and on different clinical subgroups.

    Neurologia (Barcelona, Spain)·2014
    Same author

    Neurological manifestations in Erdheim-Chester disease: Two case reports.

    Neurologia (Barcelona, Spain)·2014
    Same author

    Experience with immunotherapy in 3 patients with cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.

    Neurologia (Barcelona, Spain)·2013
    Same author

    Hirayama disease: Is surgery an option?

    Neurologia (Barcelona, Spain)·2013
    Same journal

    [Amyotrophic neuralgia secondary to Vaxzevria (AstraZeneca) COVID-19 vaccine].

    Neurologia (Barcelona, Spain)·2024
    Same journal

    [SARS-CoV-2 infection: Possible underdiagnosis of cerebral venous sinus thrombosis].

    Neurologia (Barcelona, Spain)·2024
    Same journal

    [Bell's palsy following COVID-19 vaccination: A case report].

    Neurologia (Barcelona, Spain)·2024
    Same journal

    [Parsonage-Turner syndrome post-infection by SARS-CoV-2: A case report].

    Neurologia (Barcelona, Spain)·2024
    Same journal

    [Acute transverse myelitis following SARS-CoV-2 infection].

    Neurologia (Barcelona, Spain)·2024
    Same journal

    [Neurological complications in critical patients with COVID-19].

    Neurologia (Barcelona, Spain)·2024
    See all related articles

    Area of Science:

    • Neurology
    • Molecular Biology
    • Public Health

    Background:

    • Prion diseases represent a distinct category in modern neurology, grounded in molecular understanding.
    • Despite low incidence, the transmissibility of prion diseases, exemplified by variant Creutzfeldt-Jakob disease (vCJD), raises significant public health concerns.

    Discussion:

    • European surveillance data indicate widespread underdiagnosis of prion diseases.
    • This underdiagnosis raises concerns about the capacity to identify potential future waves of atypical vCJD, particularly if clinical or pathological features evolve.
    • Current genetic-molecular subclassification approaches for prion diseases are being challenged by recent findings.

    Key Insights:

    • Prion diseases are molecularly defined neurological disorders with public health implications due to transmissibility.

    Related Experiment Videos

  • Underdiagnosis is prevalent, potentially hindering the detection of emerging or altered forms of diseases like vCJD.
  • The established genetic-molecular subclassification of prion diseases may require re-evaluation.
  • Outlook:

    • Enhanced surveillance strategies are needed to improve prion disease detection rates.
    • Further research is required to understand and potentially reclassify prion diseases based on evolving molecular and clinical data.
    • Public health preparedness must account for the potential emergence of atypical prion disease presentations.